For Wegovys cardiovascular indication, you need documented established cardiovascular disease, meaning a prior heart attack, stroke, or known coronary artery disease, plus a BMI of 27 or higher
Nsibo et al., 2024) with very little research focusing on its lifestyle and infection biology
He L, Du Z, Xiong X, Ma H, Zhu Z, Gao H, et al
WellPoint and Anthem merged in 2004
Conclusive remarks In conclusion, despite its promise, nutrition remains an underrepresented focus in clinical research, underscoring the need for robust, large-scale, evidence-based investigations
A greater understanding of the mechanisms responsible for the clinical and metabolic effects of the poly-agonists, the balance of receptor agonism needed for optimal effects, and the heterogeneity in response among individual patients and different patient populations will be important to guide future drug development and clinical application